UK.GOV: Vaccine booster doses wane after just 10 weeks

“The latest data suggests this extra protection starts to wane more rapidly, being about 15 to 25% lower from 10 weeks after the booster dose.”  More...

Vaccines: Pfizer CEO says fourth dose of vaccine may be needed sooner than expected

Pfizer CEO Albert Bourla said Wednesday that people might need a fourth Covid-19 shot sooner than expected after preliminary research shows the new Omicron variant can undermine protective antibodies generated by the vaccine the company developed with BioNTech.  More...

Preprint: Omicron incompletely escapes immunity induced by the Pfizer vaccine

Laboratory research from South Africa strongly suggests that the SARS-CoV-2 Omicron variant escapes antibody immunity induced by the Pfizer-BioNTech (Comirnaty) vaccine, but that considerable immunity is retained in people who were both vaccinated and previously infected.  More...

FFP2 masks more effective at preventing Covid infection than vaccines

Max Planck: “When both wear a surgical mask, while the infectious is speaking, the very conservative upper bound remains below 30% after 1h, but, when both wear a well-fitting FFP2 mask, it is 0.4%”

We find, for a typical SARS-CoV-2 viral load and infectious dose, that social distancing alone, even at 3m between two speaking individuals, leads to an upper bound of 90% for risk of infection after a few minutes.  More...

Preprint: Omicron is the product of extensive evolution that has left no obvious traces of intermediate forms

The Omicron variant identified in Southern Africa in late November 2021 is the product of extensive evolution within an infection context that has so far left no obvious traces of intermediate forms since it diverged from the B.1.1 lineage (presumably at some time in mid to late 2020).  More...